Industry News

Potential Alzheimer’s Disease Therapy Targets Oral Bacteria

Porphyromonas gingivalis doesn’t just cause periodontal disease. It also has been linked with Alzheimer’s and other degenerative diseases. Now, pharmaceutical company Cortexyme Inc.

Read More
Industry News

Oral Bacteria Linked to Alzheimer’s Disease

Porphyromonas gingivalis (Pg) plays a role in driving Alzheimer’s disease (AD) pathology, according to researchers at Cortexyme. But the privately held, clinical-stage pharmaceutical.

Read More